It is also well established that genetic factors predispose individuals to NAFLD and around 25% of people diagnosed with NAFLD have polymorphisms in adiponutrin (PNPLA3) (5, 6). This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.